Review | SARS-COV-2 Neutralizing Antibodies

Team Annar
Content creation
SHARE

Review SARS-COV-2 Neutralizing Antibodies

Casa Comercial Asociada: DIA.PRO


Neutralizing antibodies to SARS COV 2 are antibodies capable of stopping the binding of host cell receptors to the virus receptor located on the spicule.

They are relevant because they are the antigenic target for vaccine development, and are responsible for host protection against infection.

Currently there are in vitro diagnostic products that allow the quantification of these IgG isotype antibodies that, when used with responsibility and knowledge, will provide valuable information to improve the management of vaccines and the knowledge of this viral infection.

 

 


 

Most viewed

The artificial intelligence revolution and its application in healthcare

Gamification processes as an alternative for recruiting donors in blood banks: A review as an applicability strategy.

Transformation, innovation and expansion: the strategic evolution of medium-complexity hospitals

Resolution 2100 of 2025: A New Approach to Addressing the Consumption of Psychoactive Substances in Colombia